2342 TRANSGENIC GROUP INC. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

2342

TSE Growth

TRANSGENIC GROUP INC.

278

JPY

-37

(-11.75%)

Dec 5, 12:48 pm JST

1.79

USD

Dec 4, 10:48 pm EST

Result

PTS

outside of trading hours

276

Dec 5, 12:47 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	12,576	1,837	1,819	1,876	109.5	6	May 13, 2022	J-GAAP
Mar, 2023	11,429	-25	199	-409	-24.3	5	May 12, 2023	J-GAAP
Mar, 2024	13,083	89	108	4	0.2	3	May 10, 2024	J-GAAP
Mar, 2025	13,005	-259	-319	-1,089	-65.5	0	Jun 16, 2025	J-GAAP
Mar, 2026 Guidance	13,500	150	90	40	2.4	0	Jun 16, 2025	J-GAAP
YoY	+3.8%	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	May 12, 2020	ー	ー	ー	ー	0	J-GAAP
- - - -	Nov 12, 2020	10,500	450	400	280	0	J-GAAP
	Jan 18, 2021	11,050	800	750	575	0	J-GAAP
	Apr 30, 2021	11,000	890	890	540	3	J-GAAP
Results	May 14, 2021	11,046	893	891	546	3	J-GAAP
Mar, 2022	May 14, 2021	Available in future release
	Jul 13, 2021
	Nov 12, 2021
	Feb 14, 2022
	Apr 21, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
	Dec 7, 2022
	Feb 10, 2023
	Apr 26, 2023
Results	May 12, 2023
Mar, 2024	May 12, 2023
	Feb 9, 2024
	Apr 24, 2024
Results	May 10, 2024
Mar, 2025	May 10, 2024
	Nov 12, 2024
	Jun 13, 2025
Results	Jun 16, 2025
Mar, 2026	Jun 16, 2025	13,500	150	90	40	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2001	357	+240.0	Available in future release
Mar, 2002	193	-45.9
Mar, 2003	274	+42.0
Mar, 2004	574	+109.5
Mar, 2005	640	+11.5
Mar, 2006	470	-26.6
Mar, 2007	435	-7.4
Mar, 2008	332	-23.7
Mar, 2009	324	-2.4
Mar, 2010	603	+86.1
Mar, 2011	509	-15.6
Mar, 2012	607	+19.3
Mar, 2013	704	+16.0
Mar, 2014	1,617	+129.7
Mar, 2015	1,958	+21.1
Mar, 2016	2,290	+17.0
Mar, 2017	2,302	+0.5
Mar, 2018	3,601	+56.4
Mar, 2019	8,674	+140.9
Mar, 2020	11,046	+27.3
Mar, 2021	11,046	0.0
Mar, 2022	12,576	+13.9
Mar, 2023	11,429	-9.1
Mar, 2024	13,083	+14.5
Mar, 2025	13,005	-0.6
Mar, 2026 Guidance	13,500	+3.8	150	－	90	－	2.4	－

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	13,083	89	0.68	0.07	0.04	1.28	0.2
Mar, 2025	13,005	-259	-2.0	-20.44	-11.23	1.34	-65.5
Mar, 2026 Guidance	13,500	150	1.11	0.83	0.41	1.40	2.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	13,083	1,837	1,819	1,876	109.5
Fiscal Year	Mar, 2024	Mar, 2022	Mar, 2022	Mar, 2022	Mar, 2022

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	5,887	-159	-5	-463	-27.5	5	May 12, 2023	J-GAAP
Oct - Mar, 2023	6,706	1	14	-44	-2.6	3	May 10, 2024	J-GAAP
Oct - Mar, 2024	6,694	-149	-163	-907	-54.6	0	Jun 16, 2025	J-GAAP
Oct - Mar, 2025 Guidance	7,276	79	7	11	0.7	0	Nov 12, 2025	J-GAAP
YoY	+8.7%	－	－	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	-25	-1,646	-1,430	-216	484	3,459	32.41	J-GAAP
Mar, 2024	89	-672	-392	-280	-342	2,466	25.14	J-GAAP
Mar, 2025	-259	-193	94	-287	265	2,541	26.51	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2023	6,377	88	94	48	2.9	87.0	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	6,311	-110	-156	-182	-11.0	ー	Nov 12, 2024	J-GAAP
Apr - Sep, 2025	6,224	71	83	29	1.8	92.2	Nov 12, 2025	J-GAAP
YoY	-1.4%	－	－	－	－

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	3,366	-36	-44	-86	-5.1	-1.1	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	3,340	37	58	42	2.5	1.1	May 10, 2024	J-GAAP
Apr - Jun, 2024	2,882	-103	-117	-99	-6.0	-3.6	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	3,429	-7	-39	-83	-5.0	-0.2	Nov 12, 2024	J-GAAP
Oct - Dec, 2024	3,496	-16	-6	-109	-6.6	-0.5	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	3,198	-133	-157	-798	-48.0	-4.2	Jun 16, 2025	J-GAAP
Apr - Jun, 2025	3,197	45	61	26	1.6	1.4	Aug 12, 2025	J-GAAP
Jul - Sep, 2025	3,027	26	22	3	0.2	0.9	Nov 12, 2025	J-GAAP
YoY	-11.7%	－	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	3,178	+17.7	Available in future release
Jan - Mar, 2021	3,188	+1.1
Apr - Jun, 2021	3,313	+50.1
Jul - Sep, 2021	3,389	+37.0
Oct - Dec, 2021	2,943	-7.4
Jan - Mar, 2022	2,931	-8.1
Apr - Jun, 2022	2,470	-25.4
Jul - Sep, 2022	3,072	-9.4
Oct - Dec, 2022	2,922	-0.7
Jan - Mar, 2023	2,965	+1.2
Apr - Jun, 2023	3,280	+32.8
Jul - Sep, 2023	3,097	+0.8
Oct - Dec, 2023	3,366	+15.2
Jan - Mar, 2024	3,340	+12.6
Apr - Jun, 2024	2,882	-12.1
Jul - Sep, 2024	3,429	+10.7
Oct - Dec, 2024	3,496	+3.9
Jan - Mar, 2025	3,198	-4.3
Apr - Jun, 2025	3,197	+10.9
Jul - Sep, 2025	3,027	-11.7	26	－	22	－	0.2	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	3,496	952	938	1,074	62.7
Fiscal Year	Dec, 2024	Jun, 2021	Jun, 2021	Mar, 2022	Mar, 2022

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	356.98	56.4	10,672	6,017	2,147	0.40	May 12, 2023	J-GAAP
Mar, 2024	355.19	60.1	9,810	5,893	2,067	0.38	May 10, 2024	J-GAAP
Mar, 2025	285.98	49.7	9,586	4,762	927	0.54	Jun 16, 2025	J-GAAP
Apr - Sep, 2025	ー	49.8	9,642	4,799	957	0.60	Nov 12, 2025	J-GAAP

TRANSGENIC GROUP INC.(2342) Financial Results